HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance

Francesca Maria Carozzi, Annarosa Del Mistro, Kate Cuschieri, Helena Frayle, Cristina Sani, Elena Burroni

Research output: Contribution to journalArticlepeer-review

Abstract

This review aims to highlight the importance of Quality Assurance for Laboratories performing HPV test for Cervical Cancer Screening. An HPV test, to be used as primary screening test, must be validated according to international criteria, based on comparison of its clinical accuracy to HC2 or GP5+/6+ PCR-EIA tests. The number of validated platforms is increasing and appropriate Quality Assurance Programs (QAPs) which can interrogate longitudinal robustness and quality are paramount. This document describes the following topics: (1) the characteristics of an HPV laboratory and the personnel training needs, to ensure an elevated quality of the entire process and the optimal use of the resources; (2) the Quality Assurance, as both internal (IQA) and external quality assessment (EQA) systems, to be implemented and performed, and the description of the existing EQAs, including limitations; (3) general considerations for an optimal EQA program for hrHPV primary screening. Due to the importance of Quality Assurance for this field, international efforts are necessary to improve QA International Collaboration.

Original languageEnglish
Pages (from-to)S22-S28
JournalJournal of Clinical Virology
Volume76
DOIs
Publication statusPublished - Mar 1 2016

Keywords

  • Cervical cancer screening
  • HPV DNA testing
  • HPV EQA
  • HPV IQA
  • Quality assurance

ASJC Scopus subject areas

  • Virology
  • Infectious Diseases

Fingerprint Dive into the research topics of 'HPV testing for primary cervical screening: Laboratory issues and evolving requirements for robust quality assurance'. Together they form a unique fingerprint.

Cite this